Johannes Noé
- Oncology top 1%
- Pulmonary and Respiratory Medicine top 1%
- Molecular Biology top 10%
- Cancer Research top 2%
- Nutrition and Dietetics top 2%
- Co-authors
- Shirish M. GadgeelTony MokSolange PetersD. Ross CamidgeRafał DziadziuszkoAlice T. ShawRafael RosellJin Seok Ahn
- Topics
- Lung Cancer Treatments and Mutations (17 papers)Lung Cancer Research Studies (10 papers)Drug Transport and Resistance Mechanisms (6 papers)
- Partner nations
- SwitzerlandUnited StatesPoland
In The Last Decade
Johannes Noé
33 papers receiving 3.6k citations
Hit Papers
Peers
Comparison fields: 5 of 104
- Oncology 2.4k
- Pulmonary and Respiratory Medicine 2.2k
- Molecular Biology 717
- Cancer Research 656
- Nutrition and Dietetics 409
Countries citing papers authored by Johannes Noé
This map shows the geographic impact of Johannes Noé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johannes Noé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johannes Noé more than expected).
Fields of papers citing papers by Johannes Noé
This network shows the impact of papers produced by Johannes Noé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johannes Noé. The network helps show where Johannes Noé may publish in the future.
Co-authorship network of co-authors of Johannes Noé
This figure shows the co-authorship network connecting the top 25 collaborators of Johannes Noé. A scholar is included among the top collaborators of Johannes Noé based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Johannes Noé. Johannes Noé is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 5 | |
| 3 | Updated overall survival and final progression-free survival data for patients with treatment-naive advanced ALK-positive non-small-cell lung cancer in the ALEX studybreakdown → | 414 |
| 4 | Updated Efficacy and Safety Data and Impact of the EML4-ALK Fusion Variant on the Efficacy of Alectinib in Untreated ALK-Positive Advanced Non–Small Cell Lung Cancer in the Global Phase III ALEX Studybreakdown → | 319 |
| 5 | 40 | |
| 6 | 10 | |
| 7 | Alectinib versus Crizotinib in Untreated ALK-Positive Non–Small-Cell Lung Cancerbreakdown → | 1619 |
| 8 | 107 | |
| 9 | 3 | |
| 10 | 1 | |
| 11 | 108 | |
| 12 | 236 | |
| 13 | 95 | |
| 14 | 191 | |
| 15 | 79 | |
| 16 | 24 | |
| 17 | 32 | |
| 18 | 165 | |
| 19 | 41 | |
| 20 | 52 |
About Johannes Noé
Johannes Noé is a scholar working on Sensory Systems, Oncology and Pulmonary and Respiratory Medicine, having authored 33 papers that have together received 3.7k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (17 papers), Lung Cancer Research Studies (10 papers) and Drug Transport and Resistance Mechanisms (6 papers). The work is most often cited by research in Oncology (2.4k citations), Pulmonary and Respiratory Medicine (2.2k citations) and Sensory Systems (279 citations). Johannes Noé has collaborated with scholars based in Switzerland, United States and Poland. Frequent co-authors include Shirish M. Gadgeel, Tony Mok, Solange Peters, D. Ross Camidge, Rafał Dziadziuszko, Alice T. Shaw, Rafael Rosell, Jin Seok Ahn, M. Pérol and Bogdana Balas. Their work appears in journals such as New England Journal of Medicine, JAMA and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.